From June 19th to 21st, 2024, the 22nd CPHI & PMEC China 2024, a major annual event for the global pharmaceutical industry, was held at the Shanghai New International Expo Centre. As the largest and most influential comprehensive pharmaceutical industry exhibition in the Asia-Pacific region, this event brought together top companies and industry leaders from the global supply chain. Shanghai JSD New Medical Material Co., Ltd (hereinafter referred to as “JSD”) showcased its core innovative achievement—a high-performance co-injection cap specifically designed for BFS (Blow-Fill-Seal) infusion bottles—providing a comprehensive demonstration of the company’s profound technological accumulation and forward-looking product layout in the field of high-end medical packaging materials to domestic and international industry peers.
Against the backdrop of increasingly stringent requirements for the safety, compliance, and production efficiency of sterile preparations in the global pharmaceutical industry, BFS (Blow-Fill-Seal) technology, with its superior sterility assurance advantages, has become the mainstream choice for high-end infusion packaging. As a key component that directly contacts the medication and safeguards its ultimate safety, the performance of the cap is crucial. With its deep understanding of pharmaceutical processes and continuous investment in materials research and development, JSD has successfully launched co-injection cap products precisely matched to the advanced BFS process, committed to providing pharmaceutical companies with higher-level packaging safety and reliability solutions.
At this exhibition, JSD highlighted its co-injection cap products, showcasing its core advantages in precision manufacturing and material composite technology:
1. Innovative dual-layer structure for all-around protection: Utilizing an advanced co-injection molding process, two medical-grade polymer materials with distinct properties are precisely combined. The inner layer material possesses excellent chemical inertness and compatibility, ensuring no precipitation or adsorption during long-term contact with various drug solutions, thus guaranteeing drug stability. The outer layer material endows the product with outstanding mechanical strength, elasticity, and durability, ensuring integrity and convenience during logistics and clinical use.
2. Highly adaptable, enabling efficient production: The product design fully considers the operational requirements of BFS high-speed automated production lines, possessing extremely high dimensional accuracy and batch stability. This helps improve the operational efficiency and product qualification rate of customers’ filling lines, providing strong support for pharmaceutical companies to reduce costs and increase efficiency.
3. Compliant and reliable, in line with international standards: Products strictly comply with authoritative domestic and international regulations and standards such as the Chinese Pharmacopoeia, FDA, and EP. A comprehensive quality management system has been established and implemented to provide a solid guarantee for pharmaceutical customers’ products to meet global market access requirements.
4. Flexible customization and in-depth service: JSD has strong joint development capabilities and can provide personalized product customization and comprehensive technical services based on the specific drug properties, equipment parameters and market regulations of customers.
During the exhibition, the JSD booth attracted widespread attention and in-depth exchanges from numerous domestic and international pharmaceutical companies, research institutions, and industry experts. The company’s professional team held multiple rounds of fruitful discussions with visiting guests on BFS technology development trends, co-injection cap performance verification, industry standard updates, and potential collaborations. Many clients highly praised JSD’s innovative product design, superior quality, and professional service capabilities, resulting in lively on-site interactions and successfully establishing several high-quality cooperation bridges.
The successful showcase at the 22nd CPHI & PMEC China is not only a crucial opportunity for Shanghai JSD New Medical Material Co., Ltd to demonstrate its innovative strength to the core of the global industry chain, but also a significant milestone for the company in deepening industry cooperation and expanding its market influence. Looking ahead, JSD will continue to uphold its corporate mission of “safeguarding life and health with innovative materials,” focusing on cutting-edge technology research and development, and committed to providing safer, more efficient, and more sustainable medical packaging solutions. Together with global partners, JSD will promote technological progress in the pharmaceutical packaging industry and contribute its professional strength to safeguarding human health and well-being.
